Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Monotherapy Dose Optimization in Epilepsy
NCT01689649Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in epilepsy, sponsored by Janssen Pharmaceutical. Started May 2008; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01689649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689649.